Neuropathic pain is responsible for a major socio-economic burden and is considered as highly difficult to treat. Evidence based guidelines are mandatory to guide the appropriate use of therapies in clinical practice. In 2015 the NeuPSIG published the first international recommendations based on a large systematic review and meta-analysis for the pharmacotherapy of neuropathic pain (Finnerup et al 2015). Since these recommendations, newer therapies for neuropathic pain have emerged including drug treatments but also neurostimulation techniques, for which randomized placebo-controlled trials have also been conducted. To encompass these newer therapeutic strategies, the NeuPSIG has committed a large international group of experts of over 30 researchers, from over 10 countries, aiming to revise prior guidelines which were focused on pharmacotherapy and expand the search to neurostimulation techniques. The workshop will present the systematic review and meta-analytical methods and summarize the main results which will be used to inform the revised NeuPSIG evidence based guidelines.